Skip to Content

Brown Advisory Small-Cap Growth Adv BASAX

Medalist Rating as of | See Brown Advisory Investment Hub
  • NAV / 1-Day Return 21.15  /  −0.94 %
  • Total Assets 1.7 Bil
  • Adj. Expense Ratio
    1.380%
  • Expense Ratio 1.380%
  • Distribution Fee Level High
  • Share Class Type No Load
  • Category Small Growth
  • Investment Style Small Growth
  • Min. Initial Investment 100
  • Status Open
  • TTM Yield
  • Turnover 29%

USD | NAV as of Apr 25, 2024 | 1-Day Return as of Apr 25, 2024, 10:10 PM GMT+0

Morningstar’s Analysis BASAX

Will BASAX outperform in future?

Get our overall rating based on a fundamental assessment of the pillars below.

A sound investment process and strong management team underpin Brown Advisory Small-Cap Growth Adv's Morningstar Medalist Rating of Silver.

null Morningstar Manager Research

Morningstar Manager Research

Summary

Fees are a weakness here. The strategy's lofty fees are a high hurdle to clear, as it is priced within the second-highest quintile among peers.

Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings BASAX

  • Current Portfolio Date
  • Equity Holdings
  • Bond Holdings
  • Other Holdings
  • % Assets in Top 10 Holdings 23.4
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

First American Government Obligs Z

4.67 107.1 Mil
Cash and Equivalents

Bright Horizons Family Solutions Inc

3.50 80.1 Mil
Consumer Cyclical

ChampionX Corp

2.51 57.5 Mil
Energy

Casey's General Stores Inc

2.46 56.4 Mil
Consumer Cyclical

Prosperity Bancshares Inc

2.33 53.4 Mil
Financial Services

Bruker Corp

2.17 49.8 Mil
Healthcare

SPDR® S&P Biotech ETF

2.11 48.4 Mil

Neurocrine Biosciences Inc

2.11 48.3 Mil
Healthcare

NeoGenomics Inc

2.09 47.9 Mil
Healthcare

Encompass Health Corp

2.04 46.9 Mil
Healthcare